Pain syndrome in medical practice therapeutic potential of dexketoprofen administration
https://doi.org/10.21518/2079-701X-2019-6-47-50
Abstract
The article presents the data of modern Russian and foreign studies on the use of non-steroidal anti-inflammatory drugs (NSAID). Various types of pain are discussed. The authors outline the key issues of the choice of drugs from the NSAID group, taking into account efficacy, safety and scope of use.
About the Authors
G. G. Ketova
Federal State Budgetary Educational Institution of Higher Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Ketova Galina Grigorievna – Dr. of Sci. (Med.), Professor of Chair for Polyclinic Therapy and Clinical Pharmacology
454092, Chelyabinsk, Vorovskogo St., 64
V. O. Barysheva
Federal State Budgetary Educational Institution of Higher Education «South Ural State Medical University» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Barysheva Valeriya Olegovna – Cand. of Sci. (Med.), Assistant Professor of Chair for Polyclinic Therapy and Clinical Pharmacology
454092, Chelyabinsk, Vorovskogo St., 64
References
1. Guideliens for the management of pain sydrom. European Association of Urology, 2011. (In Russ).
2. Plotnikova E.Yu., Zolotukhina V.N., Merzlyakov S.P., et al. Nonsteroidal anti-inflammatory drugs for vertebral pain syndromes: what to choose? Comparative study. Nervnye Bolezni. 2018;2:38- 42. (In Russ).
3. Vertkin AL, Shamuilova M.M., Knorring G.Yu., Aliyev P.D. Patient with back pain at a GP’s appointement. RMJ. 2018:13-16. (In Russ).
4. Topchiy N.V., Toporkov A.S. Optimization of the use of nonsteroidal anti-inflammatory drugs in general medical practice. RMJ. 2011;19(2):27–32. (In Russ).
5. De la Lastra C.A., Nieto A., Motilva V. et al. Intestinal toxicity of ketoprofen trometamol vs its enantiomers in rat. Role of oxidative stress. Inflamm. Res. 2000;49(11):627–632.
6. Jamali F., Brocks D.R. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin. Pharmacokinet. 1990;19(3):197–217.
7. Barbanoj M.J., Antonijoan R.M., Gich I. Clinical pharmacokinetics of dexketoprofen. Clin. Pharmacokinet. 2001;940(4):245–262.
8. Vakhnina N.V., Kalimeeva E.Yu. Understanding and treating lower back pain: principles of effective and safe pain relief. Effektivnaya Farmakoterapiya. 2018;11:10-15. (In Russ).
9. Moore R.A., Barden J. Systematic review of dexketoprofen in acute and chronic pain. BMC Clin Pharmacol. 2008 Oct 31;8:11. doi: 10.1186/1472-6904-8-11.
10. Zippel H., Wagenitz A. A multicentre, randomised, double-blind study comparing the efficacy and tolerability of intramuscular dexketoprofen versus diclofenac in the symptomatic treatment of acute low back pain. Clin Drug Investig. 2007;27(8):533–543.
11. Metscher B., Kübler U., Jahnel-Kracht H. Dexketoprofen-trometamol and tramadol in acute lumbago. Fortschr Med Orig. 2001;118(4):147–151.
12. Eken C., Serinken M., Elicabuk H. et al. Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical low back pain in the emergency department: a randomised doubleblind controlled trial. Emerg Med J. 2014 Mar;31(3):177–81. doi: 10.1136/emermed-2012-201670.
13. Tunali Y., AkНil E.F., Dilmen O.K. et al. Efficacy of intravenous paracetamol and dexketoprofen on postoperative pain and morphine consumption after a lumbar disk surgery. J Neurosurg Anesthesiol. 2013 Apr;25(2):143–7. doi: 10.1097/ANA.0b013e31827464af.
14. Rodríguez M., Contreras D., Gálvez R. et al. Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain. Pain. 2003;104 (1–2):103–110.
15. Alekseeva L.I., Taskina E.A., Kashevarova N.G., et al. Evaluating the efficacy and safety of the stepwise dexketoprofen trometamol therapy in patients with acute back pain and aggravation of the osteoarthritis of large joints. Lechebnoye Delo. 2017;2:66-73. (In Russ).
16. Isaykin A.I., Rozhkov D.A., Shevtsova G.E. Muscle factor in lumbar pain. Myths and reality. Nevrologiya and Psykhiatria. 2017;3:78-85. (In Russ).
17. Carne X., Rios J., Torres F. Postmarketing cohort study to assess the safety profile of oral dexketoprofen trometamol for mild to moderate acute pain treatment in primary care. Methods Find Exp Clin Pharmacol. 2009 Oct;1(8):533-40.
18. Trukhan D.I., Ivanova D.S. Treatment of pain at the outpatient stage. The choice of analgesics from the perspective of comorbidity and drug safety. Dexketoprofen is in focus. Meditsinsky Sovet. 2017;20:56-64. (In Russ).
19. Karacabey S., Sanri E., Yalcinli S., Akoglu H. Which is more effective for the treatment of Acute Migraine Attack: Dexketoprofen, Ibuprofen or Metoclopramide? Pak J Med Sci. 2018 Mar-Apr;34(2):418-423. doi: 10.12669/pjms.342.13815.
20. Hanna M., Moon J.Y. A review of dexketoprofen trometamol in acute pain. Curr Med Res Opin. 2018 Apr;24:1-14. doi: 10.1080/03007995.2018.1457016.
21. Al B., Sunar M.M., Zengin S. et al. Comparison of IV dexketoprofen trometamol, fentanyl, and paracetamol in the treatment of renal colic in the ED: A randomized controlled trial. Am J Emerg Med. 2018 Apr;36(4):571-576. doi: 10.1016/j.ajem.2017.09.019.
22. Singh G., Triadafilopoulos S. Appropriative choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. International Journal of Clinical Practice. 2005 Oct;59(10):1210-5.
Review
For citations:
Ketova GG, Barysheva VO. Pain syndrome in medical practice therapeutic potential of dexketoprofen administration. Meditsinskiy sovet = Medical Council. 2019;(6):47-50. (In Russ.) https://doi.org/10.21518/2079-701X-2019-6-47-50
Views:
721
Email this article 